Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tagamet 200mg/5ml syrup
0103010D0BBADAD
|
Tagamet | Cimetidine | Gastro-Intestinal System | 242 |
|
Tagamet 400mg tablets
0103010D0BBABAB
|
Tagamet | Cimetidine | Gastro-Intestinal System | 2 |
|
Tagamet 100 tablets
0103010D0BBAIAK
|
Tagamet | Cimetidine | Gastro-Intestinal System | No data available |
|
Tagamet 200mg tablets
0103010D0BBAAAA
|
Tagamet | Cimetidine | Gastro-Intestinal System | No data available |
|
Tagamet 200mg/2ml solution for injection ampoules
0103010D0BBAEAE
|
Tagamet | Cimetidine | Gastro-Intestinal System | No data available |
|
Tagamet 400mg effervescent tablets
0103010D0BBAGAI
|
Tagamet | Cimetidine | Gastro-Intestinal System | No data available |
|
Tagamet 800mg tablets
0103010D0BBACAC
|
Tagamet | Cimetidine | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.